BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7044207)

  • 1. [Post kala-azar dermal leishmaniasis and "crithidia" serology (author's transl)].
    Madero López L; Iturriaga Matarranz R; Aparicio Meix M; López-Brea M
    An Esp Pediatr; 1982 Jan; 16(1):88-91. PubMed ID: 7044207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serological diagnosis of visceral leishmaniasis (kala azar) using Crithidia sp. as an antigen (preliminary report)].
    López-Brea M
    Rev Sanid Hig Publica (Madr); 1978; 52(11-12):1543-4. PubMed ID: 382338
    [No Abstract]   [Full Text] [Related]  

  • 3. [Visceral leishmaniasis (Kala-Azar) in a 3-year-old German infant (author's transl)].
    Wittermann C; Bienzle U; Betke K
    Klin Padiatr; 1979 May; 191(3):311-7. PubMed ID: 222940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnosis of visceral leishmaniasis (carried in) (author's transl)].
    Falkner von Sonnenburg F; Krampitz HE; Löscher T; Prüfer L; Weiland G
    MMW Munch Med Wochenschr; 1979 Oct; 121(42):1353-6. PubMed ID: 117316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Visceral leishmaniasis or kala-azar (author's transl)].
    Laroche R; Sirol J; Poli L
    Med Trop (Mars); 1978; 38(4):395-8. PubMed ID: 732552
    [No Abstract]   [Full Text] [Related]  

  • 6. Application of electroimmunodiffusion and crossed electroimmunodiffusion tests for the diagnosis of visceral leishmaniasis (kala-azar).
    Kohanteb J; Rezai HR; Ardehali S
    J Trop Med Hyg; 1984 Oct; 87(5):201-5. PubMed ID: 6442365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-kala-azar dermal leishmaniasis.
    Baghestani S; Handjani F; Sodeifi M; Kumar PV
    Eur J Dermatol; 1998 Jun; 8(4):277-9. PubMed ID: 9649686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes in Indian kala-azar.
    Sehgal S; Aikat BK; Pathania AG
    Bull World Health Organ; 1982; 60(6):945-50. PubMed ID: 6761008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An easily cultured Crithidia sp. as antigen for immunofluorescence for kala-azar.
    Hedge EC; Moody AH; Ridley DS
    Trans R Soc Trop Med Hyg; 1978; 72(4):445. PubMed ID: 360503
    [No Abstract]   [Full Text] [Related]  

  • 10. [Case report of skin manifestations in infantile Mediterranean kala-azar].
    Ayadi A; Loukil M; Lakhoua R; Boubaker S; Debbabi A; Ben Rachid SB; Jedidi H
    Ann Pediatr (Paris); 1992 Apr; 39(4):265-7. PubMed ID: 1616241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual presentation of post-kala-azar dermal leishmaniasis.
    Ramesh V; Kumar J; Salotra P
    Trop Doct; 2007 Jul; 37(3):172-3. PubMed ID: 17716510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serologic diagnosis by indirect immunofluorescence of visceral leishmaniasis using the protozoan Crithidia sp. as an antigen].
    López-Brea M
    Rev Sanid Hig Publica (Madr); 1979; 53(7-8):1109-15. PubMed ID: 400542
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations.
    Ramesh V
    Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544
    [No Abstract]   [Full Text] [Related]  

  • 14. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observation on complement fixation test in post-kala-azar dermal leishmaniasis.
    Mukherjee AM; Khan KP
    Bull Calcutta Sch Trop Med; 1971 Apr; 19(2):47. PubMed ID: 5161469
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serological diagnosis of visceral leishmaniasis using indirect immunofluorescence].
    López-Brea M
    Rev Clin Esp; 1983 May; 169(4):233-5. PubMed ID: 6353496
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: does ultraviolet light (UVB) radiation play a role?
    Ismail A; Khalil EA; Musa AM; El Hassan IM; Ibrahim ME; Theander TG; El Hassan AM
    Med Hypotheses; 2006; 66(5):993-9. PubMed ID: 16386855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of Leishmania parasites in skin lesions of Indian post kala-azar dermal leishmaniasis (PKDL) cases.
    Sharma MC; Gupta AK; Verma N; Das VN; Saran R; Kar SK
    J Commun Dis; 2000 Mar; 32(1):67-8. PubMed ID: 11129569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.